Halifax Treatment Refractory Depression Trial

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Depression
Interventions
BEHAVIORAL

Intensive Short-term Dynamic Psychotherapy

The ISTDP model is an emotion focused brief format of psychotherapy that helps the patients identify and address emotional factors that culminate into exacerbation of depression and perpetuation of depression. The emphasis is on awareness of emotions and how they affect the person's behavioral patterns and mood. The research protocol calls for the treatment to be delivered according to a 20-session time-limited format. The first session is an extended 2-3 hour appointment (21), then sessions are planned to occur on a weekly basis lasting 60 minutes in duration. Termination in fewer sessions is based upon agreement between therapist and patient.

BEHAVIORAL

Secondary Care Treatment as Usual

At the four secondary health care sites, treatment as usual will consist of a multidisciplinary team approach including pharmacotherapy and clinical management, supportive or structured activities focused around symptom management and in some cases, individual or group psychotherapy. Pharmacotherapy treatment strategies will be individualized regimes informed by evidence-based recommendations. TAU will not be regulated in order to get a naturalistic assessment of standard secondary care treatment delivery with the exception that trial participants not be offered a psychodynamic / psychoanalytic based psychotherapy treatment during the course of the trial. Therapeutic interventions are likely to be heterogeneous therefore the trial coordinator will document in detail the dose and approaches delivered to each participant in order to account for this heterogeneity.

Trial Locations (1)

B3H 2E2

Capital District Health Authority, Halifax

All Listed Sponsors
collaborator

Nova Scotia Health Authority

OTHER

lead

Joel Town

OTHER

NCT01141426 - Halifax Treatment Refractory Depression Trial | Biotech Hunter | Biotech Hunter